| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5730471 | The Journal of Sexual Medicine | 2016 | 8 Pages |
Abstract
These data suggest that spironolactone use in transgender women increases HDL levels and that CPA has the opposite effect. CPA also is associated with a larger increase in prolactin. These factors should be considered when choosing between these two antiandrogen agents.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Raymond MD, BSc, Miriam BSc, Camille BSc, Iliana MD, MSc, Leah MD, PhD,